3SBio (TRSBF) Total Liabilities: $826 Mil (As of Dec. 2025)


TRSBF 3SBio Inc TRSBF
90 GF Score
Price $2.15
GF Value $1.61
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is 3SBio Total Liabilities?

3SBio TRSBF -2.27% 90 Total Liabilities is $826 Mil as of Dec. 2025. GuruFocus rates TRSBF with a GF Score™ of 90/100 and a GF Value™ of $1.61 (Significantly Overvalued). The stock has 1 warning sign investors should review.

3SBio's Total Liabilities for the quarter that ended in Dec. 2025 was $826 Mil.

3SBio's quarterly Total Liabilities declined from Dec. 2024 ($848.33 Mil) to Jun. 2025 ($680.60 Mil) but then increased from Jun. 2025 ($680.60 Mil) to Dec. 2025 ($825.50 Mil).

3SBio's annual Total Liabilities declined from Dec. 2023 ($995.97 Mil) to Dec. 2024 ($848.33 Mil) and declined from Dec. 2024 ($848.33 Mil) to Dec. 2025 ($825.50 Mil).

3SBio Total Liabilities Historical Data

* Premium members only.

The historical data trend for 3SBio's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio Total Liabilities Chart

3SBio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 715.11 953.19 995.97 848.33 825.50

3SBio Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 995.97 974.58 848.33 680.60 825.50
TRSBF
90GF Score
3SBio Inc TRSBF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3SBio Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

3SBio's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=626.943+(109.062+89.497
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=826

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=5146.856-4321.354
=826

3SBio's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=626.943+(109.062+89.497
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=826

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=5146.856-4321.354
=826

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $826 Mil mean?
3SBio (TRSBF) has a Total Liabilities of $826 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for 3SBio and its competitors.
Is 3SBio's Total Liabilities too high?
3SBio's current Total Liabilities is $826 Mil. Overall, 3SBio has a GF Score™ of 90/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3SBio's Total Liabilities compare to VRTX and REGN?
3SBio's Total Liabilities of $826 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for 3SBio and its competitors. 3SBio's current Total Liabilities is $826 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3SBio stock overvalued right now?
Based on GuruFocus' analysis, 3SBio (TRSBF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.61, compared to a current price of $2.15 — trading 33.5% above its estimated fair value. The current Total Liabilities is $826 Mil. 3SBio's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For 3SBio (TRSBF), the current Total Liabilities is $826 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3SBio (TRSBF) Overvalued in 2026?

Based on GuruFocus' analysis, 3SBio stock appears to be overvalued. The current stock price of $2.15 is trading 33.5% above its estimated GF Value™ of $1.61. GuruFocus considers 3SBio to be Significantly Overvalued.

Key valuation signals for TRSBF:

  • Total Liabilities: $826 Mil
  • GF Value™: $1.61 vs. price of $2.15 (33.5% above fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the TRSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3SBio Business Description

Other Exchanges 01530:Hong Kong83B:Germany
Address No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
90GF Score

Get the complete analysis for TRSBF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.15
Price
$1.61
GF Value